Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 14/6/20121 min de lectura
Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 31, 2012 (77 FR 32124). The document announced the availability of a guidance for industry entitled "Irritable Bowel Syndrome--Clinical Evaluation of Drugs for Treatment." The document was published with an incorrect docket number. This document corrects that error.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →